| 【Company Research】Netease (NTES US) – Aiming for long-term growth |
| 【Company Research】Yidu Tech (2158 HK) – Eyes on post-COVID business recovery |
| 【Company Research】Dingdang Health (9886 HK) – 2022 preview: Continuing to enhance long-term growth logic |
| 【Company Research】Baidu (BIDU US) – Strong AI capability to empower business growth |
| 【Company Research】Mobvista Inc. (1860 HK) – Recovery in sight with clear margin expansion |
| 【Sector Research】China Consumer Sector – Shenzhen Trip: sustained growth in Feb 2023 |
| 【Company Research】PA Good Doctor (1833 HK) – 2022 preview: Solid business development through the bumpy 2022 |
| 【Company Research】Ke Holdings (BEKE US) – Existing home sales recovery to be better than anticipated |
| 【Company Research】Glodon (002410 CH) – Clear operating leverage from SaaS |
| 【Company Research】ZhongAn (6060 HK) – FY22 preview: 2H22 UW margin improvement |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
